ALK-Abelló
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
ALK | CO
Overview
Corporate Details
- ISIN(s):
- DK0061802139
- LEI:
- 529900SGCREUZCZ7P020
- Country:
- Denmark
- Address:
- Bøge Alle 6-8, 2970 Hørsholm
- Website:
- https://www.alk.net
- Sector:
- Manufacturing
Description
ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-17 20:43 | Danish | HTML • 1.5 KB | |||
| 2022-05-17 20:43 | English | HTML • 1.5 KB | |||
| 2022-05-17 20:43 |
Report on transactions with ALK-Abelló A/S B-shares and associated securities b…
|
Danish | PDF • 191.5 KB | ||
| 2022-05-17 20:43 |
Report on transactions with ALK-Abelló A/S B-shares and associated securities b…
|
Danish | PDF • 194.1 KB | ||
| 2022-03-29 10:30 |
Total share capital and voting rights
|
Danish | PDF • 92.3 KB | ||
| 2022-03-29 10:30 |
Total share capital and voting rights
|
Danish | HTML • 2.7 KB | ||
| 2022-03-29 10:30 |
Total share capital and voting rights
|
Danish | PDF • 93.7 KB | ||
| 2022-03-29 10:30 |
Total share capital and voting rights
|
Danish | HTML • 2.7 KB | ||
| 2022-03-24 17:15 | English | HTML • 5.0 KB | |||
| 2022-03-24 17:15 | Danish | PDF • 124.1 KB | |||
| 2022-03-24 17:15 |
Grant of share options and performance shares to members of the Board of Manage…
|
Danish | HTML • 4.7 KB | ||
| 2022-03-24 17:15 |
Grant of share options and performance shares to members of the Board of Manage…
|
Danish | PDF • 124.9 KB | ||
| 2022-03-03 12:32 | Danish | PDF • 204.3 KB | |||
| 2022-03-03 12:32 | English | PDF • 206.1 KB | |||
| 2022-03-03 12:32 |
Clinical trial waiver in China opens door to 2022 registration filing for ALK’s…
|
Danish | HTML • 5.5 KB |
Automate Your Workflow. Get a real-time feed of all ALK-Abelló filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ALK-Abelló
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ALK-Abelló via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
